Clinical Trials Logo
  1. Home
  2. Subdural Hematoma
  3. NCT04402632

Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma — EMBOLISE  

Subdural Hematoma Clinical Trial

Official title:
A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE)

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the Onyx™ Liquid Embolic System (LES) for treatment of symptomatic subacute or chronic subdural hematoma (SDH)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04402632
Study type Interventional
Source Medtronic Neurovascular Clinical Affairs
Contact Medtronic Neurovascular Clinical Affairs
Phone 1(949) 837-3700
Email rs.embolisestudy@medtronic.com
Status Recruiting
Phase N/A
Start date October 27, 2020
Completion date March 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT03496545 - Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury Phase 1/Phase 2
Terminated NCT05472766 - Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma N/A
Not yet recruiting NCT06052124 - Augmented Reality for Subdural Drain Placement N/A
Completed NCT02368366 - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI N/A
Terminated NCT01463878 - Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study Phase 4
Not yet recruiting NCT06119932 - Evaluation of One Burr Hole Evacuation for Subdural Hematoma
Completed NCT02618382 - A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population Phase 4
Recruiting NCT04923984 - Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can) N/A
Completed NCT03153150 - Start or STop Anticoagulants Randomised Trial (SoSTART) Phase 3
Completed NCT04270955 - Dartmouth Middle Meningeal Embolization Trial (DaMMET) N/A
Recruiting NCT06067750 - Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
Not yet recruiting NCT05713630 - The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma Phase 3
Withdrawn NCT01605357 - Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury Phase 1/Phase 2
Withdrawn NCT04500795 - Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma N/A
Recruiting NCT04170582 - Patient Registry for Patients With Chronic Subdural Hematoma
Recruiting NCT05649904 - AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis N/A
Recruiting NCT04211233 - Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE) N/A